Biotech Currents
Substacknewsletter · by Biotech Currents · English
Clinical & Regulatory Catalysts Driving BioPharma & MedTech Stocks Started by SanaCurrents ("SC"), a service established to identify which stocks, valued entirely on the promise of developing a new, novel drug, has the best chance for value appreciation.
- Audience
- Not shown publicly
- We show a dash rather than guess
- Observed frequency
- Monthly or less
- From 1 post indexed in the last 90 days
- Last post
- Oct 15, 2026
- 27 days ago
- Likely audience
- biotech investors
- Inferred from post content
Biotech Currents is a Substack newsletter by Biotech Currents covering biotech investment, Clinical trial analysis and Biotech stock market. NewsletterFIT indexed 1 post from it in the last 90 days, most recently on Oct 15, 2026.
Topics
- biotech investment
- Clinical trial analysis
- Biotech stock market
- Systemic lupus erythematosus
- New Drug Application
Recent posts
- Did Investors…
- Biomatrix Device…
- The Overlooked…
- Revenue rising…
- A High-Probability…
Sponsors detected
No sponsored posts detected in the last 180 days of indexed posts.
Detected automatically from posts marked as sponsored. Detection can miss or misread placements.
See the full picture on Biotech Currents
Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.
Biotech Currents alternatives: similar newsletters
Ranked by how many topics they share with Biotech Currents.
- The Century of Biology28K subscribers
Substacklast post Jun 21, 2026
Likely audience: Biotech investors
1 shared topic
beehiivEvery two weeks · last post 21 days ago
Likely audience: biotech investors
1 shared topic
Compiled from public pages · refreshed Nov 10, 2026 · How NewsletterFIT collects and labels data